mutations and sophisticated kar yotype. It follows a linear evolution in the CLL clone throughout the recurrent acquisition of CDKN2A??? "???????????????????????????????????????????????"102 On the flip side, various groups are advocating to the incorporation of novel markers, for instance a complex karyotype55 or epigenetic subsets, 27,28 into clin